Geode Capital Management LLC Lowers Position in Chemed Corporation $CHE

Geode Capital Management LLC lessened its holdings in Chemed Corporation (NYSE:CHE) by 2.3% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 358,114 shares of the company’s stock after selling 8,442 shares during the quarter. Geode Capital Management LLC’s holdings in Chemed were worth $153,245,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Alps Advisors Inc. raised its position in shares of Chemed by 32.4% in the third quarter. Alps Advisors Inc. now owns 44,295 shares of the company’s stock worth $19,833,000 after buying an additional 10,845 shares in the last quarter. SG Americas Securities LLC raised its position in shares of Chemed by 773.5% in the fourth quarter. SG Americas Securities LLC now owns 26,466 shares of the company’s stock worth $11,324,000 after buying an additional 23,436 shares in the last quarter. Intech Investment Management LLC purchased a new stake in shares of Chemed in the third quarter worth $1,429,000. Envestnet Asset Management Inc. raised its position in shares of Chemed by 6.5% in the third quarter. Envestnet Asset Management Inc. now owns 80,080 shares of the company’s stock worth $35,855,000 after buying an additional 4,865 shares in the last quarter. Finally, Bahl & Gaynor Inc. raised its position in shares of Chemed by 15.4% in the third quarter. Bahl & Gaynor Inc. now owns 20,042 shares of the company’s stock worth $8,974,000 after buying an additional 2,673 shares in the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on CHE. Wall Street Zen upgraded Chemed from a “hold” rating to a “buy” rating in a research report on Sunday, May 31st. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Royal Bank Of Canada increased their target price on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a research note on Monday, April 27th. Weiss Ratings raised Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, April 29th. Finally, Oppenheimer reduced their target price on Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a research note on Friday, February 27th. Two equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $501.50.

Chemed Stock Up 1.1%

CHE opened at $431.70 on Friday. The stock has a market cap of $5.73 billion, a PE ratio of 23.53, a P/E/G ratio of 1.60 and a beta of 0.54. The company has a quick ratio of 0.83, a current ratio of 0.85 and a debt-to-equity ratio of 0.11. Chemed Corporation has a 52 week low of $365.20 and a 52 week high of $565.66. The business’s fifty day simple moving average is $408.07 and its 200 day simple moving average is $424.45.

Chemed (NYSE:CHE) last released its earnings results on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, beating analysts’ consensus estimates of $5.30 by $0.35. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The business had revenue of $657.51 million for the quarter, compared to analysts’ expectations of $659.22 million. During the same quarter in the prior year, the firm earned $5.63 earnings per share. The firm’s revenue was up 1.6% on a year-over-year basis. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. As a group, research analysts expect that Chemed Corporation will post 22.3 earnings per share for the current fiscal year.

Chemed Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th will be issued a $0.60 dividend. The ex-dividend date is Thursday, May 28th. This represents a $2.40 annualized dividend and a dividend yield of 0.6%. Chemed’s payout ratio is currently 13.08%.

Insider Activity at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Friday, May 1st. The stock was sold at an average price of $421.13, for a total value of $842,260.00. Following the transaction, the chief executive officer owned 90,219 shares in the company, valued at approximately $37,993,927.47. The trade was a 2.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 3.33% of the company’s stock.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.